tiprankstipranks
Advertisement
Advertisement
Lepu Biopharma Sets March 25 Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsLepu Biopharma Sets March 25 Board Meeting to Approve 2025 Annual Results
2M ago
Lepu Biopharma Signals 2025 Profit on Strong Oncology Sales and Licensing Gains
Premium
Company Announcements
Lepu Biopharma Signals 2025 Profit on Strong Oncology Sales and Licensing Gains
2M ago
Lepu Biopharma Gains US$45 Million Milestone as AstraZeneca Advances Claudin 18.2 ADC to Phase III
Premium
Company Announcements
Lepu Biopharma Gains US$45 Million Milestone as AstraZeneca Advances Claudin 18.2 ADC to Phase III
2M ago
Lepu Biopharma Enters New Procurement Agreement with Lepu Medical
PremiumCompany AnnouncementsLepu Biopharma Enters New Procurement Agreement with Lepu Medical
6M ago
Lepu Biopharma Announces Supervisor Resignation
Premium
Company Announcements
Lepu Biopharma Announces Supervisor Resignation
7M ago
Lepu Biopharma Gains Approval for Innovative Cancer Drug in China
Premium
Company Announcements
Lepu Biopharma Gains Approval for Innovative Cancer Drug in China
7M ago
Lepu Biopharma Completes H Share Full Circulation to Enhance Market Presence
PremiumCompany AnnouncementsLepu Biopharma Completes H Share Full Circulation to Enhance Market Presence
10M ago
Lepu Biopharma Completes HK$462.94 Million H Share Placement
Premium
Company Announcements
Lepu Biopharma Completes HK$462.94 Million H Share Placement
10M ago
Lepu Biopharma Announces HK$462.94 Million H Share Placement
Premium
Company Announcements
Lepu Biopharma Announces HK$462.94 Million H Share Placement
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100